Glucagon
Stories
-
Novo Nordisk posts results of Phase 3 dasiglucagon vs glucagon study in Asian adults with T1D
The study, completed with 38 participants, compared dasiglucagon and glucagon for treating severe hypoglycaemia in Asian adults with type 1 diabetes. Results were first posted on ClinicalTrials.gov on November 16, 2026.